Pfizer on OTC sale
This article was originally published in The Tan Sheet
Executive Summary
Bids for Pfizer's OTC division during a June 6 auction reportedly topped $15 bil., while bidders included GlaxoSmithKline, Johnson & Johnson and Reckett Benckiser. Pfizer says it is still maintaining the option of spinning the division off to shareholders 1("The Tan Sheet" May 29, 2006 p. 6 ). "The review is continuing, and we will be announcing which of the strategic options [we choose] in the third quarter," a Pfizer spokesman said...